We are hiring! Click to View Open Positions.

Posters

October 2021

2021 World Congress of Neurology (WCN)

Relationship of Pharmacokinetics and Pharmacodynamics to Apitegromab Efficacy in Patients with Later-onset Spinal Muscular Atrophy (Types 2 and 3 SMA): Results from the TOPAZ Study (Poster #EP1150)

View This Poster

September 2021

2021 Child Neurology Society (CNS) Annual Meeting

Efficacy of Apitegromab in Patients with Later-Onset Spinal Muscular Atrophy (SMA Types 2 and 3): Responder Analysis from the Phase 2 TOPAZ Study (#310)

View This Poster

September 2021

World Muscle Society 2021 Virtual Congress

Insights into the Potential Pharmacological Effects of Apitegromab in Health and Disease: Data from Preclinical and Clinical Studies (EP.277)

View This Poster

September 2021

World Muscle Society 2021 Virtual Congress

Apitegromab in Spinal Muscular Atrophy (SMA): An Analysis of Multiple Efficacy Endpoints in the TOPAZ Trial (LBP.10)

View This Poster

June 2021

Virtual 2021 7th Congress of the European Academy of Neurology (EAN)

Apitegromab, an Investigational Anti-proMyostatin Monoclonal Antibody for Spinal Muscular Atrophy: Phase 2 Results (Presentation)

View This Poster

June 2021

2021 American Society of Clinical Oncology (ASCO) Annual Meeting

First-in-Human Phase 1 Trial (DRAGON) of SRK-181: A Potential First-in-Class Selective Latent TGFβ1 Inhibitor, Alone or in Combination with Anti-PD-(L)1 Treatment in Patients with Advanced Solid Tumors

View This Poster